What is IBS-D Phase III Ibodutant IRIS-3 Study?
CATEGORY:
The IBS-D IRIS-3 study is a clinical trial examining the efficacy and safety of oral ibodutant for women experiencing irritable bowel syndrome with diarrhea.
Save up to 80% off your prescriptions!
We currently don't have enough shared data that is made public for this treatment.
Let's build this page together! When you share what it's like to have IBS-D Phase III Ibodutant IRIS-3 Study through your profile, those stories and data appear here too.
Last updated: